December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Orca Bio

News headline image
Orca Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Orca Bio
Via Business Wire
News headline image
Orca Bio Announces Orca-T® Phase 3 Data Published in Blood Demonstrate Significant Improvement in Survival Free from Chronic Graft versus Host Disease in Patients with Hematological Malignancies
From Orca Bio
Via Business Wire
News headline image
Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting
From Orca Bio
Via Business Wire
News headline image
Orca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 67th American Society of Hematology Annual Meeting
From Orca Bio
Via Business Wire
News headline image
Orca Bio Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Orca-T® to Treat Hematological Malignancies
From Orca Bio
Via Business Wire
News headline image
Orca Bio Appoints Key Executives Including Steve Gavel as Chief Commercial Officer
From Orca Bio
Via Business Wire
News headline image
Orca Bio Announces Leadership Updates
From Orca Bio
Via Business Wire
News headline image
Orca Bio Announces Positive Results from the Pivotal Phase 3 Study of Investigational Orca-T® Compared to Allogeneic Stem Cell Transplant for the Treatment of Hematologic Malignancies
From Orca Bio
Via Business Wire
News headline image
Orca Bio’s Orca-T® Meets Primary Endpoint in the Pivotal Precision-T Phase 3 Clinical Study for Hematologic Malignancies
From Orca Bio
Via Business Wire
News headline image
Orca Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Orca Bio
Via Business Wire
News headline image
Orca Bio Presents Three-Year Survival Data with Orca-T® in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
From Orca Bio
Via Business Wire
News headline image
Orca Bio Presents Clinical Results on Use of Orca-Q® without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
From Orca Bio
Via Business Wire
News headline image
Orca Bio to Present Clinical Data on Its High-Precision Cell Therapies at the 66th American Society of Hematology Annual Meeting
From Orca Bio
Via Business Wire
News headline image
Orca Bio Announces Completion of Patient Enrollment for the Precision-T Phase 3 Study of Orca-T
From Orca Bio
Via Business Wire
News headline image
Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
From Orca Bio
Via Business Wire
News headline image
Orca Bio to Present Positive Clinical Data on Orca-T at the 50th Annual Meeting of the EBMT
From Orca Bio
Via Business Wire
News headline image
Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
From Orca Bio
Via Business Wire
News headline image
Orca Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Orca Bio
Via Business Wire
News headline image
Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting
From Orca Bio
Via Business Wire
News headline image
Orca Bio to Present Positive Clinical Data on its Novel High-Precision Cell Therapies at the 65th American Society of Hematology Annual Meeting
From Orca Bio
Via Business Wire
News headline image
Orca Bio Presents Positive Data Reinforcing Clinical Profile of Orca-T and Orca-Q at 2023 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
From Orca Bio
Via Business Wire
News headline image
Orca Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Orca Bio
Via Business Wire
News headline image
Orca Bio Presents Encouraging Interim Clinical Data on Orca-Q in Haploidentical Allogeneic Hematopoietic Stem Cell Transplants at 64th ASH Annual Meeting
From Orca Bio
Via Business Wire
News headline image
Orca Bio Presents Data Demonstrating its Lead Investigational High-Precision Cell Therapy Orca-T Significantly Improved Relapse-Free Survival at 64th ASH Annual Meeting
From Orca Bio
Via Business Wire
News headline image
Orca Bio to Present Four Abstracts at the 64th American Society of Hematology Annual Meeting, Including Updated Relapse-Free Survival Data with Orca-T and the First Clinical Data for Orca-Q
From Orca Bio
Via Business Wire
News headline image
Orca Bio Expands Manufacturing Capabilities to Develop and Commercialize its Precision Cell Therapies
From Orca Bio
Via Business Wire
News headline image
Orca Bio Announces the Precision-T Phase 3 Study is Open and Enrolling Patients at Transplant Centers Across the U.S.
From Orca Bio
Via Business Wire
News headline image
Orca Bio to Present New Clinical Data on Orca-T at the European Hematology Association 2022 Congress
From Orca Bio
Via Business Wire
News headline image
Orca Bio Presents Positive Data Reinforcing Clinical Profile and Manufacturing Reliability of Orca-T at 2022 Transplantation & Cellular Therapy ASTCT and CIBMTR Tandem Meetings
From Orca Bio
Via Business Wire
News headline image
Orca Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference
From Orca Bio
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.